REVERZINE INJECTION 오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

reverzine injection

elanco australasia pty ltd - yohimbine hydrochloride - parenteral liquid/solution/suspension - yohimbine hydrochloride alkaloid active 10.0 mg/ml - antidotes - cattle | deer | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | doe | fallow deer - reversal of xylazine based sedation

Dexdor 유럽 연합 - 영어 - EMA (European Medicines Agency)

dexdor

orion corporation - dexmedetomidine hydrochloride - conscious sedation - psycholeptics - for sedation of adult intensive care unit patients requiring a sedation level not deeper than arousal in response to verbal stimulation (corresponding to richmond agitation-sedation scale (rass) 0 to -3).

Triton Depth of Anesthesia and Sedation Monitor 싱가포르 - 영어 - HSA (Health Sciences Authority)

triton depth of anesthesia and sedation monitor

radiance medical systems - anaesthesiology - the device is intended for continuous monitoring of brain activity index (ai), the main parameter defined by the device, calculated by analyzing patient’s electroencephalogram (eeg) in the time and frequency domains. also it defines optional parameters: eeg signal suppression rate (sr); eeg signal quality index (sqi); electromyographic component level (emg). the device is intended for assessment and long-term monitoring of patient‘s depth of anaesthesia and sedation: in medical institutions, operating rooms, anesthesiology departments and groups, resuscitations and intensive care departments for adults and children; specialized departments rooms; anesthesiology and resuscitation centers; in intraoperative, preoperative, preparatory and postoperative period; during invasive diagnostic interventions and intensive therapy at anesthetic sedative exposure.

Byfavo 유럽 연합 - 영어 - EMA (European Medicines Agency)

byfavo

paion deutschland gmbh - remimazolam besilate - conscious sedation - psycholeptics - remimazolam is indicated in adults for procedural sedation.remimazolam 50 mg is indicated in adults for intravenous induction and maintenance of general anaesthesia.

Remifentanil-AFT, remifentanil (as hydrochloride) 2 mg, powder for injection, glass vial 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

remifentanil-aft, remifentanil (as hydrochloride) 2 mg, powder for injection, glass vial

aft pharmaceuticals pty ltd - remifentanil hydrochloride, quantity: 2.194 mg (equivalent: remifentanil, qty mg) - injection, powder for - excipient ingredients: hydrochloric acid; glycine - remifentanil is indicated:,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures but not cardiac procedures in children aged 1 to 12 years,? for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery,when endotracheal intubation and controlled ventilation are anticipated.,? for provision of analgesia and sedation in mechanically ventilated intensive care patients.

Remifentanil-AFT, remifentanil (as hydrochloride) 5 mg, powder for injection, glass vial 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

remifentanil-aft, remifentanil (as hydrochloride) 5 mg, powder for injection, glass vial

aft pharmaceuticals pty ltd - remifentanil hydrochloride, quantity: 5.485 mg (equivalent: remifentanil, qty mg) - injection, powder for - excipient ingredients: hydrochloric acid; glycine - remifentanil is indicated:,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures but not cardiac procedures in children aged 1 to 12 years,? for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery,when endotracheal intubation and controlled ventilation are anticipated.,? for provision of analgesia and sedation in mechanically ventilated intensive care patients.

Remifentanil-AFT, remifentanil (as hydrochloride) 1 mg, powder for injection, glass vial 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

remifentanil-aft, remifentanil (as hydrochloride) 1 mg, powder for injection, glass vial

aft pharmaceuticals pty ltd - remifentanil hydrochloride, quantity: 1.097 mg (equivalent: remifentanil, qty mg) - injection, powder for - excipient ingredients: hydrochloric acid; glycine - remifentanil is indicated:,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures but not cardiac procedures in children aged 1 to 12 years,? for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery,when endotracheal intubation and controlled ventilation are anticipated.,? for provision of analgesia and sedation in mechanically ventilated intensive care patients.

Cisatracurium-AFT, 150mg/30mL, Solution for injection/infusion, vial 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

cisatracurium-aft, 150mg/30ml, solution for injection/infusion, vial

aft pharmaceuticals pty ltd - cisatracurium besilate, quantity: 0.669 % w/v - solution - excipient ingredients: benzenesulfonic acid; water for injections - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Cisatracurium-AFT, 20mg/10mL, Solution for injection/infusion, Ampoules 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

cisatracurium-aft, 20mg/10ml, solution for injection/infusion, ampoules

aft pharmaceuticals pty ltd - cisatracurium besilate, quantity: 0.268 % w/v - solution - excipient ingredients: water for injections; benzenesulfonic acid - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.